# Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)

> **NCT05172765** · NA · RECRUITING · sponsor: **University of Oklahoma** · enrollment: 160 (estimated)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DEVICE:** Transcutaneous Electrical Nerve Stimulation Device

## Key facts

- **NCT ID:** NCT05172765
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-14
- **Primary completion:** 2025-10-31
- **Final completion:** 2026-05-29
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05172765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05172765, "Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05172765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*